Will availability of inhaled human insulin (Exubera<sup>®</sup>) improve management of type 2 diabetes? The design of the <it>Real World trial</it>
<p>Abstract</p> <p>Background</p> <p>Common deterrents to insulin therapy for both physicians and patients are the complexity and burden of daily injections. In January 2006, the first inhaled human insulin (INH, Exubera<sup>® </sup>(insulinhuman [rDNA origi...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2006-08-01
|
| Series: | Trials |
| Online Access: | http://www.trialsjournal.com/content/7/1/25 |